Literature DB >> 27622055

Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments.

Elisabetta Cariani1, Massimo Pilli2, Valeria Barili2, Emanuela Porro2, Elisabetta Biasini2, Andrea Olivani2, Raffaele Dalla Valle3, Tommaso Trenti1, Carlo Ferrari2, Gabriele Missale2.   

Abstract

NK-cell number and function have been associated with cancer progression. A detailed analysis of phenotypic and functional characteristics of NK-cells in HCC is still lacking. NK-cell function is regulated by activating and inhibitory receptors determined by genetic factors and engagement with cognate ligands on transformed or infected cells. We evaluated phenotypic and functional characteristic of NK-cells in HCC patients undergoing curative treatment in relation to clinical outcome. NK-cells from 70 HCC patients undergoing resection or ablative treatment, 18 healthy volunteers and 12 cirrhotic patients with HCV-infection (controls) were phenotypically characterized. Unsupervised clustering based on the frequency of cells expressing different phenotypic NK-cell markers segregated HCC patients into different cohorts that were compared for outcome. NK-cell cytokine production and cytotoxicity were compared between cohorts with different overall survival (OS) and time to disease recurrence (TTR). By multivariate analysis, age, Child-Pugh class and NK-cell phenotypic clustering could independently identify patients with significantly different OS. NK-cells from patients with better outcome expressed higher levels of cytotoxic granules and CD3ζ and lower levels of natural cytotoxic receptors (NCRs) that were co-expressed with the inhibitory receptor NKG2A known to negatively regulate NCR function. Cytotoxic function and IFNγ production were significantly lower in the cohort of patients with worse outcome compared to controls (p < 0.05). Our results show a role for NK-cells in the control of HCC progression and survival providing the basis for the development of immunotherapeutic strategies to potentiate NK-cell response.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); hepatitis C virus (HCV); natural killer cells (NK); radiofrequency thermal ablation (RTA); surgical resection (SR)

Year:  2016        PMID: 27622055      PMCID: PMC5007972          DOI: 10.1080/2162402X.2016.1154249

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  24 in total

1.  Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence.

Authors:  Hiroteru Kamimura; Satoshi Yamagiwa; Atsunori Tsuchiya; Masaaki Takamura; Yasunobu Matsuda; Shogo Ohkoshi; Makoto Inoue; Toshifumi Wakai; Yoshio Shirai; Minoru Nomoto; Yutaka Aoyagi
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

2.  Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Authors:  Emilie Mamessier; Aude Sylvain; Marie-Laure Thibult; Gilles Houvenaeghel; Jocelyne Jacquemier; Rémy Castellano; Anthony Gonçalves; Pascale André; François Romagné; Gilles Thibault; Patrice Viens; Daniel Birnbaum; François Bertucci; Alessandro Moretta; Daniel Olive
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

3.  Tumor immunoediting by NKp46.

Authors:  Moran Elboim; Roi Gazit; Chamutal Gur; Hormas Ghadially; Gili Betser-Cohen; Ofer Mandelboim
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

Review 4.  Natural killer cells and solid tumors.

Authors:  Ana Stojanovic; Adelheid Cerwenka
Journal:  J Innate Immun       Date:  2011-04-18       Impact factor: 7.349

5.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.

Authors:  Yan Wu; Dong-Ming Kuang; Wei-Dong Pan; Yun-Le Wan; Xiang-Ming Lao; Dian Wang; Xue-Feng Li; Limin Zheng
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

Review 7.  Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?

Authors:  Theresa L Whiteside
Journal:  Cancer Immunol Immunother       Date:  2004-04-29       Impact factor: 6.968

Review 8.  Innate immune cell networking in hepatitis C virus infection.

Authors:  Banishree Saha; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

9.  Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

Authors:  Bastian Hoechst; Torsten Voigtlaender; Lars Ormandy; Jaba Gamrekelashvili; Fei Zhao; Heiner Wedemeyer; Frank Lehner; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

10.  Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer.

Authors:  Yun-Peng Peng; Yi Zhu; Jing-Jing Zhang; Ze-Kuan Xu; Zhu-Yin Qian; Cun-Cai Dai; Kui-Rong Jiang; Jun-Li Wu; Wen-Tao Gao; Qiang Li; Qing Du; Yi Miao
Journal:  J Transl Med       Date:  2013-10-20       Impact factor: 5.531

View more
  16 in total

Review 1.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network.

Authors:  Kelly A Borges; Jianliang Dai; Neehar D Parikh; Myron Schwartz; Mindie H Nguyen; Lewis R Roberts; Alex S Befeler; Sudhir Srivastava; Jo Ann Rinaudo; Ziding Feng; Jorge A Marrero; K Rajender Reddy
Journal:  Contemp Clin Trials       Date:  2018-11-12       Impact factor: 2.226

3.  The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds.

Authors:  Xiaohui Duan; Yi Cai; Tingting He; Xiaoliang Shi; Juan Zhao; Hui Zhang; Yao Shen; Hongjian Zhang; Heng Zhang; Wenbin Duan; Bo Jiang; Xianhai Mao
Journal:  J Gastrointest Oncol       Date:  2021-08

4.  Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinoma.

Authors:  Markus Bo Schoenberg; Tong Zhu; Jingcheng Hao; Julian Nikolaus Bucher; Xiaokang Li; Xinyu Li; Yongsheng Han; Dionysios Koliogiannis; Michaela Svihla; Markus Otto Guba; Jens Werner; Alexandr V Bazhin
Journal:  Cancer Immunol Immunother       Date:  2021-09-28       Impact factor: 6.630

Review 5.  Emerging immunotherapy for HCC: A guide for hepatologists.

Authors:  Friedrich Foerster; Simon Johannes Gairing; Sumera Irie Ilyas; Peter Robert Galle
Journal:  Hepatology       Date:  2022-04-07       Impact factor: 17.298

Review 6.  Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.

Authors:  Amber G Bozward; Frazer Warricker; Ye H Oo; Salim I Khakoo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

7.  Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis.

Authors:  Kate Childs; Elliot Merritt; Aisling Considine; Alberto Sanchez-Fueyo; Kosh Agarwal; Marc Martinez-Llordella; Ivana Carey
Journal:  Open Forum Infect Dis       Date:  2017-04-03       Impact factor: 3.835

Review 8.  Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.

Authors:  Pil Soo Sung; Jeong Won Jang
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

Review 9.  Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals.

Authors:  Ivan Schietroma; Giuseppe Corano Scheri; Claudia Pinacchio; Maura Statzu; Arnolfo Petruzziello; Vincenzo Vullo
Journal:  Open Virol J       Date:  2018-02-28

10.  Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.

Authors:  Alessandra Zecca; Valeria Barili; Danila Rizzo; Andrea Olivani; Elisabetta Biasini; Diletta Laccabue; Raffaele Dalla Valle; Carlo Ferrari; Elisabetta Cariani; Gabriele Missale
Journal:  Cells       Date:  2021-03-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.